Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
313.64
+5.59 (1.81%)
At close: Sep 5, 2025, 4:00 PM
314.00
+0.36 (0.11%)
After-hours: Sep 5, 2025, 7:56 PM EDT
Elevance Health Revenue
Elevance Health had revenue of $49.78B in the quarter ending June 30, 2025, with 14.04% growth. This brings the company's revenue in the last twelve months to $189.25B, up 10.21% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$189.25B
Revenue Growth
+10.21%
P/S Ratio
0.38
Revenue / Employee
$1,816,257
Employees
104,200
Market Cap
70.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ELV News
- 2 days ago - Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States - Business Wire
- 4 days ago - Top 15 High-Growth Dividend Stocks For September 2025 - Seeking Alpha
- 15 days ago - Elevance Health - Piggy Bank Or Headache? - Seeking Alpha
- 17 days ago - Elevance Health loses bid to challenge US Medicare star ratings - Reuters
- 18 days ago - Elevance Health and National Association of Community Health Centers Partnership Integrates Food as Medicine With Primary Care - Business Wire
- 4 weeks ago - 3 SWANs On Sale - Seeking Alpha
- 4 weeks ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 5 weeks ago - Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - Business Wire